- Published at
- by globalbankingandfinance.com
mixed
mixed
US$ 1.1 Bn Hypoparathyroidism Treatment Market Still in Infancy
The global hypoparathyroidism treatment landscape that only gained much significance post the FDA approval of Natpara in 2015, is projected grow at a rather